CRISPR/Cas9 technology generated an alanine to valine substitution at amino acid 98 (p.A98V). This missense mutation within the proximal DNA binding domain was identified in early-onset colorectal cancer patients. (J:338869)
查看原文 参与反馈
CRISPR/Cas9 technology generated an alanine to valine substitution at amino acid 98 (p.A98V). This missense mutation within the proximal DNA binding domain was identified in early-onset colorectal cancer patients. (J:338869)